PD-1 is a coinhibitory molecule in activated T cells and a well-known marker of CD8+ T cell exhaustion, a condition that is characterized by impaired effector function and is frequently observed in the setting of both chronic viral infection and malignant tumors (33, 34). Here, PDCD1 is linked to cancer.